✦ LIBER ✦

Cisplatin and 5-fluorouracil infusion in patients with recurrent and disseminated epidermoid cancer of the head and neck

✍ Scribed by Julie A. Kish; Arthur Weaver; John Jacobs; Glenn Cummings; Muhyi Al-Sarraf

Publisher: John Wiley and Sons
Year: 1984
Tongue: English
Weight: 754 KB
Volume: 53
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19840501)53:9<1819::aid-cncr2820530903>3.0.co;2-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four-day continuous infusion of cisplati

Four-day continuous infusion of cisplatin and 5-fluorouracil in head and neck cancer

✍ Amalia G. Bernal; Juan J. Cruz; Pedro Sánchez; Angel Muñoz; Adelaida Nieto; Emil 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 2 views

The activity of a single-agent 5-fluorou

The activity of a single-agent 5-fluorouracil infusion in advanced and recurrent head and neck cancer

✍ Efstathios Tapazoglou; Julie Kish; John Ensley; Muhyi Al-Sarraf 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 561 KB

Continuous cisplatin (24-hour) and 5-flu

Continuous cisplatin (24-hour) and 5-fluorouracil (120-hour) infusion in recurrent head and neck squamous cell carcinoma

✍ Asit J. Choksi; Waun K. Hong; Isaiah W. Dimery; Priscilla James; Oscar M. Guilla 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 416 KB 👁 4 views

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

cis-Platinum and 5-fluorouracil as initi

cis-Platinum and 5-fluorouracil as initial therapy in advanced epidermoid cancers of the head and neck

✍ Weaver, Arthur ;Fleming, Susan ;Vandenberg, Henry ;Drelichman, Anibal ;Jacobs, J 📂 Article 📅 1982 🏛 Wiley (John Wiley & Sons) ⚖ 397 KB

## Abstract A total of 44 patients with previously untreated Stage IV squamous cell carcinomas of the head and neck were treated with a combination of cis‐platinum (100 mg/sq m) and 96‐hour infusion of 5‐fluorouracil (5‐FU) (1,000 mg/sq m/day) in two courses or with cis‐platinum (100 mg/sq m) and 1

Weekly 5-fluorouracil plus cisplatin for

Weekly 5-fluorouracil plus cisplatin for concurrent chemoradiotherapy in patients with locally advanced head and neck cancer

✍ Young Joo Lee; Chang Geol Lee; Byoung Chul Cho; Gwi Eon Kim; Hye Jin Choi; Eun C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

## Abstract ## Background. In locally advanced head and neck cancer, concurrent chemoradiotherapy (CRT) with combined 5‐fluorouracil (5‐FU) and cisplatin has increased acute toxicities as well as survival. Once‐weekly chemotherapeutic administration schedule may reduce severe toxicities. Thus, we